Hubert Duran
Paul Sabatier University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hubert Duran.
Journal of Medicinal Chemistry | 2011
Prithwiraj De; Georges Koumba Yoya; Patricia Constant; Florence Bedos-Belval; Hubert Duran; Nathalie Saffon; Mamadou Daffé; Michel Baltas
Tuberculosis, HIV coinfection with TB, emergence of multidrug-resistant TB, and extensively drug-resistant TB are the major causes of death from infectious diseases worldwide. Because no new drug has been introduced in the last several decades, new classes of molecules as anti-TB drugs are urgently needed. Herein, we report the synthesis and structure-activity relationships of a series of thioester, amide, hydrazide, and triazolophthalazine derivatives of 4-alkoxy cinnamic acid. Many compounds exhibited submicromolar minimum inhibitory concentrations against Mycobacterium tuberculosis strain (H(37)Rv). Interestingly, compound 13e, a 4-isopentenyloxycinnamyl triazolophthalazine derivative, was found to be 100-1800 times more active than isoniazid (INH) when tested for its ability to inhibit the growth of INH-resistant M. tuberculosis strains. The results also revealed that 13e does not interfere with mycolic acid biosynthesis, thereby pointing to a different mode of action and representing an attractive lead compound for the development of new anti-TB agents.
Antioxidants & Redox Signaling | 2011
Benaissa Bouguerne; Nadji Belkheiri; Florence Bedos-Belval; Cécile Vindis; Koji Uchida; Hubert Duran; Marie-Hélène Grazide; Michel Baltas; Robert Salvayre; Anne Nègre-Salvayre
Reactive oxygen species (ROS) generated within the vascular wall trigger low-density lipoprotein (LDL) oxidation, lipid peroxidation, and carbonyl stress that are involved in atherogenesis. We recently reported that the antihypertensive drug, hydralazine, exhibits carbonyl scavenger and antiatherogenic properties, but only moderate antioxidant activity, so that high concentrations are required for inhibiting LDL oxidation. We aimed to develop agents sharing both antioxidant and carbonyl scavenger properties. We have synthesized a new hydralazine derivative, the bisvanillyl-hydralazone (BVH). BVH strongly inhibited LDL oxidation induced by copper and by human endothelial cells (HMEC-1), and prevented the formation of macrophagic foam cells. BVH reduced both the extracellular generation of ROS (superoxide anion and hydrogen peroxide) induced by oxidized LDL (oxLDL), as well as intracellular oxidative stress and proteasome activation, NFkappaB activation, and oxLDL-mediated proinflammatory signaling. In parallel, BVH prevented the carbonyl stress induced by oxLDL on cellular proteins, and blocked the apoptotic cascade as assessed by the inhibition of Bid cleavage, cytochrome C release, and DEVDase activation. Lastly, BVH prevented atherogenesis and carbonyl stress in apoE(-/-) mice. In conclusion, BVH is the prototype of a new class of antioxidant and carbonyl scavenger agents designed for new therapeutical approaches in atherosclerosis.
Polyhedron | 1993
Abdessalam Bouayad; Najib Bitit; Eric Deydier; Marie-Joëlle Menu; Michèle Dartiguenave; Yves Dartiguenave; Hubert Duran; Liliane Gorrichon; Michel Simard; André L. Beauchamp
Abstract The reaction of the title ligand N-(2-pyridyl)-3-phenyl-2-propene amide (O-N) with MX2 salts yields compounds of the type M(O-N)2X2 and [M(O-N)2(H2O)2]X2, which were characterized by elemental analysis, magnetic moments and IR and EPR spectroscopies. From the IR spectra the ligand is found to be bidentate via the pyridyl nitrogen and the amide oxygen, except in [Pd(O-N)2Cl2] where only the pyridyl ring is coordinated. The magnetic moments, IR spectra and thermograms of the M(O-N)2(NO3)2·3H2O compounds [M = nickel(II), cobalt(II)] are consistent with the presence of trans-[M(O-N)2(H2O)2]2+ ions, similar to the trans-[Zn(O-N)2(CH3OH)2]2+ species observed earlier. The EPR spectra of the trans-Cu(O-N)2X2 compounds (X = NO3−, CF3SO3−) indicate an elongated octahedral coordination with equatorial bidentate (O-N) ligands and solvent molecules or anions in axial sites. The solid-state spectra reveal the presence of more than one type of copper(II) centre. The crystal structure of trans-Cu(O-N)2(CF3SO3)2 was determined by X-ray diffraction. The unit cell contains two types of discrete trans-Cu(O-N)2(CF3SO3)2 molecules, in which bidentate (O-N) ligands are strongly bonded to the equatorial sites of a tetragonally distorted octahedron. The axial positions are filled by
Bioorganic & Medicinal Chemistry Letters | 1996
J.-Ph Roblin; Hubert Duran; Elisabeth Duran; V Banuls; Liliane Gorrichon
Abstract β-O-4 lignin model compounds have been synthesized using a new recurrent method affording dimers and trimers with controlled stereochemistry and bearing an aldehyde group.
Tetrahedron Letters | 2003
Caroline Lapeyre; Florence Bedos-Belval; Hubert Duran; Michel Baltas; Liliane Gorrichon
Abstract The one-pot transesterification of diethylarylvinylphosphonates with N -acetylcysteamine has been achieved using phosphonochloridates as intermediates. Reaction of phosphonodiesters with (COCl) 2 gave the corresponding chlorinated compounds, which were coupled with N -acetylcysteamine in presence of Et 3 N.
Journal of Medicinal Chemistry | 2008
Mélanie Delomenède; Florence Bedos-Belval; Hubert Duran; Cécile Vindis; Michel Baltas; Anne Nègre-Salvayre
Bioorganic & Medicinal Chemistry | 2007
Dina Rakotondramanana; Mélanie Delomenède; Michel Baltas; Hubert Duran; Florence Bedos-Belval; Philippe Rasoanaivo; Anne Nègre-Salvayre; Heinz Gornitzka
Journal of Medicinal Chemistry | 2005
Caroline Lapeyre; Mélanie Delomenède; Florence Bedos-Belval; Hubert Duran; Anne Nègre-Salvayre; Michel Baltas
Chemistry: A European Journal | 2000
Jean-Philippe Roblin; Hubert Duran; Elisabeth Duran; Liliane Gorrichon; Bruno Donnadieu
Planta Medica | 1999
Lyn Udino; Jacqueline Abaul; Paul Bourgeois; Liliane Gorrichon; Hubert Duran; Chantal Zedde